Search results
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 15 hours agoFollicular lymphoma (FL) is a chronic disease that accounts for about 20% of non-Hodgkin's lymphoma...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 4 days agoVertex Pharmaceuticals has reported long-term data for its gene therapy Casgevy (exa-cel) in...
New data showcase promise, growing pains of CAR-T in autoimmune disease
BioPharma Dive via Yahoo Finance· 19 hours agoOne expert described trial results presented at EULAR last week as “unprecedented.” But reports of...
Study: In severe COVID-19 cases, neutrophils work around the clock
Medical Xpress· 14 hours agoThe key players at the cellular level are neutrophils (immune cells) and endothelial cells (blood vessel lining cells), as the group writes in Cell Reports. Anyone seeking ...
Scientists solve decades long mystery of NLRC5 sensor function in cell death
Medical Xpress· 3 days agoThe innate immune system is responsible for protecting the human body from threats that could cause ...
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena via Yahoo Finance· 20 hours agoWe therefore believe Calquence plus chemoimmunotherapy will be an important new option for patients...
Shining a light on World Sickle Cell Awareness Day. Learn more about this rare blood disorder
Delaware Online | The News Journal via Yahoo News· 7 days agoAround 100,000 people in the U. S. — including an estimated 600 to 700 people in Delaware — and...
What New Gene Therapy Means For Sickle Cell Patients
Forbes· 3 days agoRecently, a 12-year-old boy became the first patient with sicklecell disease to begin commercially approved gene therapy that could potentially cure the...
New Study Suggests Cancer Drug Could Be Used to Ta | Newswise
Newswise· 1 day agoIn studies with genetically engineered mice, Johns Hopkins Medicine researchers say they have identified a potentially new biological target involving Aplp1, a cell surface ...
Novel gene-editing therapy continues to show positive results in sickle cell patients
Medical Xpress· 3 days agoHematology Association 2024 Hybrid Congress (EHA) in Madrid, Spain. This innovative treatment...